BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

TOMM20 as a potential therapeutic target of colorectal cancer

  • Park, Sang-Hee (Department of Biomedicine & Health Sciences, Graduate School, The Catholic University of Korea) ;
  • Lee, Ah-Reum (Department of Biomedicine & Health Sciences, Graduate School, The Catholic University of Korea) ;
  • Choi, Keonwoo (Department of Biomedicine & Health Sciences, Graduate School, The Catholic University of Korea) ;
  • Joung, Soyoung (Department of Biomedicine & Health Sciences, Graduate School, The Catholic University of Korea) ;
  • Yoon, Jong-Bok (Department of Biochemistry, College of Life Science & Biotechnology, Yonsei University) ;
  • Kim, Sungjoo (Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea)
  • Received : 2019.10.15
  • Accepted : 2019.11.21
  • Published : 2019.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Translocase of outer mitochondrial membrane 20 (TOMM20) plays an essential role as a receptor for proteins targeted to mitochondria. TOMM20 was shown to be overexpressed in various cancers. However, the oncological function and therapeutic potential for TOMM20 in cancer remains largely unexplored. The purpose of this study was to elucidate the underlying molecular mechanism of TOMM20's contribution to tumorigenesis and to explore the possibility of its therapeutic potential using colorectal cancer as a model. The results show that TOMM20 overexpression resulted in an increase in cell proliferation, migration, and invasion of colorectal cancer (CRC) cells, while siRNA-mediated inhibition of TOMM20 resulted in significant decreases in cell proliferation, migration, and invasion. TOMM20 expression directly impacted the mitochondrial function including ATP production and maintenance of membrane potential, which contributed to tumorigenic cellular activities including regulation of S phase cell cycle and apoptosis. TOMM20 was overexpressed in CRC compared to the normal tissues and increased expression of TOMM20 to be associated with malignant characteristics including a higher number of lymph nodes and perineural invasion in CRC. Notably, knockdown of TOMM20 in the xenograft mouse model resulted in a significant reduction of tumor growth. This is the first report demonstrating a relationship between TOMM20 and tumorigenesis in colorectal cancer and providing promising evidence for the potential for TOMM20 to serve as a new therapeutic target of colorectal cancer.

Keywords

References

  1. Siegel RL, Miller KD and Jemal A (2017) Cancer Statistics, 2017. CA Cancer J Clin 67, 7-30 https://doi.org/10.3322/caac.21387
  2. Devetzi M, Kosmidou V, Vlassi M et al (2016) Death receptor 5 (DR5) and a 5-gene apoptotic biomarker panel with significant differential diagnostic potential in colorectal cancer. Sci Rep 6, 36532 https://doi.org/10.1038/srep36532
  3. Tsouma A, Aggeli C, Lembessis P et al (2010) Multiplex RT-PCR-based detections of CEA, CK20 and EGFR in colorectal cancer patients. World J Gastroenterol 16, 5965-5974
  4. Sotgia F, Whitaker-Menezes D, Martinez-Outschoorn UE et al (2012) Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the "reverse Warburg effect" in positive lymph node tissue. Cell Cycle 11, 1445-1454 https://doi.org/10.4161/cc.19841
  5. Birsoy K, Wang T, Chen WW, Freinkman E, Abu-Remaileh M and Sabatini DM (2015) An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis. Cell 162, 540-551 https://doi.org/10.1016/j.cell.2015.07.016
  6. Wilde L, Roche M, Domingo-Vidal M et al (2017) Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development. Semin Oncol 44, 198-203 https://doi.org/10.1053/j.seminoncol.2017.10.004
  7. Schieber M and Chandel NS (2014) ROS function in redox signaling and oxidative stress. Curr Biol 24, R453-462 https://doi.org/10.1016/j.cub.2014.03.034
  8. Chacinska A, Koehler CM, Milenkovic D, Lithgow T and Pfanner N (2009) Importing mitochondrial proteins: machineries and mechanisms. Cell 138, 628-644 https://doi.org/10.1016/j.cell.2009.08.005
  9. Wise DR, Ward PS, Shay JE et al (2011) Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alphaketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci U S A 108, 19611-19616 https://doi.org/10.1073/pnas.1117773108
  10. Curry JM, Tuluc M, Whitaker-Menezes D et al (2013) Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer. Cell Cycle 12, 1371-1384 https://doi.org/10.4161/cc.24092
  11. Zhao Z, Han F, He Y et al (2014) Stromal-epithelial metabolic coupling in gastric cancer: stromal MCT4 and mitochondrial TOMM20 as poor prognostic factors. Eur J Surg Oncol 40, 1361-1368 https://doi.org/10.1016/j.ejso.2014.04.005
  12. Curry JM, Tassone P, Cotzia P et al (2016) Multicompartment metabolism in papillary thyroid cancer. Laryngoscope 126, 2410-2418 https://doi.org/10.1002/lary.25799
  13. Mikkilineni L, Whitaker-Menezes D, Domingo-Vidal M et al (2017) Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment. Semin Oncol 44, 218-225 https://doi.org/10.1053/j.seminoncol.2017.10.003
  14. Lee AR, Park J, Jung KJ, Jee SH and Kim-Yoon S (2016) Genetic variation rs7930 in the miR-4273-5p target site is associated with a risk of colorectal cancer. Onco Targets Ther 9, 6885-6895 https://doi.org/10.2147/OTT.S108787
  15. Caino MC, Ghosh JC, Chae YC et al (2015) PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion. Proc Natl Acad Sci U S A 112, 8638-8643 https://doi.org/10.1073/pnas.1500722112
  16. Rivadeneira DB, Caino MC, Seo JH et al (2015) Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion. Sci Signal 8, ra80 https://doi.org/10.1126/scisignal.aab1624
  17. Porporato PE, Payen VL, Perez-Escuredo J et al (2014) A mitochondrial switch promotes tumor metastasis. Cell Rep 8, 754-766 https://doi.org/10.1016/j.celrep.2014.06.043
  18. Sciacovelli M, Goncalves E, Johnson TI et al (2016) Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature 537, 544-547 https://doi.org/10.1038/nature19353
  19. Wang C, Shao L, Pan C et al (2019) Elevated level of mitochondrial reactive oxygen species via fatty acid betaoxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition. Stem Cell Res Ther 10, 175 https://doi.org/10.1186/s13287-019-1265-2
  20. Li Y, Yu H, Han F, Wang M, Luo Y and Guo X (2018) Biochanin A Induces S Phase Arrest and Apoptosis in Lung Cancer Cells. Biomed Res Int 2018, 3545376 https://doi.org/10.1155/2018/3545376
  21. Zhang J, Wen X, Liu N et al (2017) Epigenetic mediated zinc finger protein 671 downregulation promotes cell proliferation and tumorigenicity in nasopharyngeal carcinoma by inhibiting cell cycle arrest. J Exp Clin Cancer Res 36, 147 https://doi.org/10.1186/s13046-017-0621-2
  22. Li MX and Dewson G (2015) Mitochondria and apoptosis: emerging concepts. F1000Prime Rep 7, 42 https://doi.org/10.12703/p7-42
  23. Suzuki R, Hotta K and Oka K (2015) Spatiotemporal quantification of subcellular ATP levels in a single HeLa cell during changes in morphology. Sci Rep 5, 16874 https://doi.org/10.1038/srep16874
  24. Chen GQ, Benthani FA, Wu J, Liang D, Bian ZX and Jiang X (2019) Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis. Cell Death Differ [Epub ahead of print]